Clinical Trials Study
Copyright ©The Author(s) 2019.
World J Clin Cases. Aug 26, 2019; 7(16): 2217-2226
Published online Aug 26, 2019. doi: 10.12998/wjcc.v7.i16.2217
Table 4  χ2 analysis of acute coronary syndrome according to blocked major coronary artery variables
Complication
TVD
Mortality
No, n (%)IHF, n (%)VT, n (%)AV Block, n (%)PE/CT, n (%)APE, n (%)No, n (%)Yes, n (%)No, n (%)Yes, n (%)
RCA128 (9.8)74 (5.7)11 (0.8)24 (1.8)6 (0.4)5 (0.4)165 (12.7)184 (14.2)243 (20)37 (2.8)
R123 (1.8)8 (0.7)0 (0)6 (0.4)0 (0)1 (0.1)26 (2)47 (3.6)26 (2)4 (0.3)
R232 (2.5)12 (0.9)0 (0)3 (0.2)1 (0.1)0 (0)32 (2.5)45 (3.4)36 (2.7)1 (0.1)
R334 (2.6)15 (1.1)1 (0.1)4 (0.3)0 (0)1 (0.1)46 (3.5)23 (1.8)45 (3.5)4 (0.3)
R418 (1.4)11 (0.8)0 (0)1 (0.1)1 (0.1)5 (0.4)29 (2.2)11 (0.8)33 (2.5)7 (0.5)
L74 (5.7)6 (0.4)14 (1)9 (0.8)4 (0.3)5 (0.4)81 (6.2)47 (3.6)75 (5.7)17 (1.3)
L178 (6.2)127 (9.8)18 (6)5 (0.4)5 (0.4)23 (1.8)93 (7.1)169 (13)192 (14.8)31 (2.4)
L2133 (10.3)119 (9.1)16 (1.2)7 (0.5)7 (0.6)19 (1.5)181 (14)94 (7.2)269 (20.7)43 (3.3)
L1A37 (2.8)4 (0.3)13 (1)1 (0.1)0 (0)12 (0.9)163 (12.3)7 (0.6)53 (4.1)7 (0.5)
L1B23 (1.8)8 (0.7)4 (0.3)2 (0.1)0 (0)4 (0.3)42 (2.1)4 (0.3)37 (2.8)1 (0.1)
L1C12 (0.9)2 (0.1)5 (0.4)1 (0.1)0 (0)2 (0.1)27 (2)4 (0.3)23 (1.8 )4 (0.3)
L2A43 (3.3)9 (0.8)2 (0.1)0 (0)2 (0.1)5 (0.4)61 (4.7)6 (0.5)58 (4.5)9 (0.8)
L2B22 (1.7)4 (0.3)1 (0.1)0 (0)1 (0.1)1 (0.1)30 (2.3)6 (0.5)32 (2.5)0 (0)
L2C8 (0.6)3 (0.2)1 (0.1)1 (0.1)0 (0)0 (0)14 (11.)2 (0.1)15 (1.1)1 (0.1)
χ21631.09102.3219.51
P-value0.0010.0010.001